poisar

Stock

Relmada Therapeutics, Inc. RLMD

$4.55+0.22%

Overview

RLMD market data

Price History

RLMD price chart · 1M
O
4.51
H
4.58
L
4.49
C
4.55
Vol
31,751.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$4.51
Previous Close
$4.54
Day High
$4.58
Day Low
$4.49
52 Week High
$7.99
52 Week Low
$4.36
7 Day Return
-2.26%
30 Day Return
-13.17%
90 Day Return
-36.98%
1 Year Return
-38.22%
Daily Notional Volume
$144.5K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.45
Diluted earnings per share over the trailing twelve months.
Beta
0.49
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-500.0%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.60 – $8.00
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $508.3M · P/B 4.09.

Company News

8 captured
8-K filing — RELMADA THERAPEUTICS, INC. (RLMD)SEC EDGAR · Aug 6, 2026, 8:40 PM
Relmada Therapeutics Q2 EPS $(0.11) Beats $(0.20) EstimateBenzinga · Aug 6, 2026, 8:10 PM
Relmada Therapeutics Joins Russell 2000® and Russell 3000® IndexesGlobenewswire Inc · Jun 29, 2026, 11:15 AM
Relmada Therapeutics Joins Russell 2000 Index And Russell 3000 IndexBenzinga · Jun 29, 2026, 11:15 AM
Relmada's Cancer Drug Candidate Sparks Fresh Bullish CallBenzinga · Jun 18, 2026, 5:45 PM
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga · Jun 18, 2026, 11:50 AM
Hewlett Packard Enterprise Posts Blowout Q2 Earnings, Joins Marvell Technology And Other Big Stocks Moving Higher In Tuesday's SessionBenzinga · Jun 2, 2026, 12:20 PM
Relmada Therapeutics Increases Authorized Common Stock From 150M To 200M Shares Following Shareholder ApprovalBenzinga · May 28, 2026, 9:24 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Relmada Therapeutics, Inc. (RLMD) stock — price, valuation & news | Poisar